Simplex Trading, LLC Repligen Corp Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Repligen Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 4,157 shares of RGEN stock, worth $518,502. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,157
Previous 7,021 40.79%
Holding current value
$518,502
Previous $885,000 30.17%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$119.79 - $167.35 $343,078 - $479,290
-2,864 Reduced 40.79%
4,157 $618,000
Q2 2024

Jul 25, 2024
BUY
$120.0 - $182.95 $842,520 - $1.28 Million
7,021 New
7,021 $885,000
Q3 2023

Nov 01, 2023
SELL
$138.78 - $176.51 $40,662 - $51,717
-293 Reduced 10.75%
2,433 $386,000
Q2 2023

Aug 04, 2023
BUY
$138.42 - $180.31 $377,332 - $491,525
2,726 New
2,726 $385,000
Q1 2021

Apr 26, 2021
SELL
$180.37 - $226.26 $488,261 - $612,485
-2,707 Closed
0 $0
Q4 2020

Feb 02, 2021
BUY
$148.08 - $206.57 $308,006 - $429,665
2,080 Added 331.74%
2,707 $518,000
Q3 2020

Oct 14, 2020
SELL
$122.51 - $158.27 $271,359 - $350,568
-2,215 Reduced 77.94%
627 $92,000
Q2 2020

Jul 13, 2020
BUY
$94.33 - $140.48 $268,085 - $399,244
2,842 New
2,842 $351,000
Q2 2019

Jul 26, 2019
SELL
$54.2 - $85.95 $758 - $1,203
-14 Closed
0 $0
Q1 2019

Apr 18, 2019
SELL
$49.45 - $62.8 $230,733 - $293,024
-4,666 Reduced 99.7%
14 $0
Q4 2018

Jan 16, 2019
BUY
$48.26 - $68.88 $225,856 - $322,358
4,680 New
4,680 $246,000
Q1 2018

Apr 26, 2018
SELL
$30.92 - $37.27 $76,155 - $91,796
-2,463 Closed
0 $0
Q4 2017

Jan 10, 2018
SELL
$32.53 - $38.92 $39,751 - $47,560
-1,222 Reduced 33.16%
2,463 $89,000
Q3 2017

Oct 25, 2017
BUY
$36.98 - $46.06 $136,271 - $169,731
3,685
3,685 $141,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email